Company Filing History:
1 out of 133 
1 out of 441 
Years Active: 2024
Title: The Innovative Mind of Takashi Matozaki: Pioneering Anti-SIRPα Antibody Research
Introduction: Takashi Matozaki, a dedicated inventor based in Kobe, Japan, has made significant strides in the field of biotechnology. With a focus on developing novel therapeutic agents, Matozaki has secured a patent for an innovative anti-SIRPα antibody that holds promise for tumor treatment.
Latest Patents: Matozaki's most notable patent features an anti-SIRPα antibody that functions as both a tumor agent and an anti-tumor agent, incorporating the antibody as an active ingredient. This unique antibody specifically binds to human SIRPα, effectively inhibiting the interaction between human SIRPα and CD47, which plays a role in tumor evasion of the immune system.
Career Highlights: Throughout his career, Takashi Matozaki has been affiliated with prestigious institutions, including Kobe University and Daiichi Sankyo Company, Limited. His dedication to research and innovation has established him as a key figure in the biotechnology sector.
Collaborations: Matozaki has had the opportunity to collaborate with talented colleagues, including Mayumi Sue and Kensuke Nakamura. These partnerships have fostered a collaborative environment that encourages groundbreaking research and development.
Conclusion: Takashi Matozaki's contributions to the field of biotechnology, particularly with his anti-SIRPα antibody patent, showcase his innovative spirit and commitment to improving cancer treatment. His continued work at reputable institutions underscores the importance of collaboration in driving advancements in medical science.